CTI BIOPHARMA CORP Quarterly Operating Income (Loss) in USD from Q2 2010 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Cti Biopharma Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q1 2023.
  • Cti Biopharma Corp Operating Income (Loss) for the quarter ending March 31, 2023 was -$9.23M, a 73.7% increase year-over-year.
  • Cti Biopharma Corp Operating Income (Loss) for the twelve months ending March 31, 2023 was -$53.9M, a 52.4% increase year-over-year.
  • Cti Biopharma Corp annual Operating Income (Loss) for 2022 was -$79.8M, a 16.3% increase from 2021.
  • Cti Biopharma Corp annual Operating Income (Loss) for 2021 was -$95.3M, a 99.6% decline from 2020.
  • Cti Biopharma Corp annual Operating Income (Loss) for 2020 was -$47.8M, a 17.3% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$53.9M -$9.23M +$25.9M +73.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$79.8M -$13.6M +$21.8M +61.6% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-06
Q3 2022 -$102M -$12.2M +$11.2M +47.7% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 -$113M -$18.9M +$623K +3.19% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-08
Q1 2022 -$113M -$35.1M -$18M -106% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$95.3M -$35.4M -$20.6M -139% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$74.8M -$23.4M -$12.3M -112% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$62.4M -$19.5M -$9.51M -95.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$52.9M -$17.1M -$5.14M -43.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$47.8M -$14.8M -$5.32M -56.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$42.4M -$11M -$1.33M -13.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$41.1M -$10M +$997K +9.07% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$42.1M -$11.9M -$1.4M -13.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$40.7M -$9.47M -$9.68M -4655% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-17
Q3 2019 -$31M -$9.71M +$5.06M +34.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$36.1M -$11M +$3.01M +21.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$39.1M -$10.5M -$6.2M -143% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$32.9M $208K +$13.9M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 -$46.8M -$14.8M -$3M -25.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-04
Q2 2018 -$43.8M -$14M -$19.3M -366% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 -$24.5M -$4.34M +$15M +77.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$39.5M -$13.7M -$8.15M -147% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$31.4M -$11.8M +$16.9M +58.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$48.3M $5.27M +$24.3M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$72.6M -$19.3M -$23.4M -568% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$49.2M -$5.56M +$20.6M +78.8% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-07
Q3 2016 -$69.8M -$28.7M +$3.29M +10.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$73.1M -$19.1M +$12M +38.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 -$85.1M $4.13M +$31.6M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$117M -$26.2M +$13.2M +33.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 -$130M -$32M -$39.4M -528% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 -$90.4M -$31M -$4.36M -16.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$86.1M -$27.5M +$180K +0.65% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$86.2M -$39.4M -$49.7M -481% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-02
Q3 2014 -$36.5M $7.47M +$23M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$59.5M -$26.7M -$8.82M -49.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-06
Q1 2014 -$50.7M -$27.7M -$9.14M -49.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 -$41.5M $10.3M +$29.2M Oct 1, 2013 Dec 31, 2013 10-K 2016-02-17
Q3 2013 -$70.7M -$15.5M -$336K -2.22% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-31
Q2 2013 -$70.4M -$17.9M +$31.5M +63.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-04
Q1 2013 -$102M -$18.5M -$424K -2.34% Jan 1, 2013 Mar 31, 2013 10-Q 2014-04-29
Q4 2012 -$101M -$18.9M -$8.94M -90.2% Oct 1, 2012 Dec 31, 2012 10-K 2013-02-28
Q3 2012 -$92.6M -$15.1M +$141K +0.92% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-30
Q2 2012 -$92.7M -$49.4M -$32.5M -192% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-31
Q1 2012 -$60.2M -$18.1M +$1.97M +9.83% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-02
Q4 2011 -$62.2M -$9.91M Oct 1, 2011 Dec 31, 2011 10-K 2013-02-28
Q3 2011 -$15.3M -$2.3M -17.7% Jul 1, 2011 Sep 30, 2011 10-K 2013-02-28
Q2 2011 -$16.9M +$2.76M +14% Apr 1, 2011 Jun 30, 2011 10-K 2013-02-28
Q1 2011 -$20.1M Jan 1, 2011 Mar 31, 2011 10-K 2013-02-28
Q3 2010 -$13M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-25
Q2 2010 -$19.7M Apr 1, 2010 Jun 30, 2010 10-Q 2011-07-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.